Evercore ISI Group reiterated coverage on TG Therapeutics with a new price target
$TGTX
Biotechnology: Pharmaceutical Preparations
Health Care
Evercore ISI Group reiterated coverage of TG Therapeutics with a rating of Outperform and set a new price target of $36.00 from $55.00 previously